Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:approvalYear |
September 2017
|
| gptkbp:ATCCode |
L01EM23
|
| gptkbp:CASNumber |
1032754-93-2
|
| gptkbp:chemicalFormula |
C23H28N6O4
|
| gptkbp:form |
solution for infusion
|
| gptkbp:genericName |
gptkb:copanlisib
|
| https://www.w3.org/2000/01/rdf-schema#label |
Aliqopa
|
| gptkbp:indication |
relapsed follicular lymphoma
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:manufacturer |
gptkb:Bayer
|
| gptkbp:mechanismOfAction |
PI3K inhibitor
|
| gptkbp:pregnancyCategory |
not recommended
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
gptkb:pneumonia
diarrhea hypertension leukopenia hyperglycemia |
| gptkbp:target |
gptkb:PI3K-delta
gptkb:PI3K-alpha |
| gptkbp:bfsParent |
gptkb:copanlisib
|
| gptkbp:bfsLayer |
5
|